Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-Specific Expression of the EWSR1::FLI1 Fusion Protein Identifies <i>col2a1a</i>-Positive Cells as a Source of Ewing Sarcoma-like Tumors in Zebrafish.

International journal of molecular sciences·2026
Same author

Hog1/p38 and ZAKα drive Shwachman-Diamond syndrome and provide targets to improve cell growth.

bioRxiv : the preprint server for biology·2026
Same author

Oral and Dental Management in Children With Congenital Neutropenia.

Pediatric blood & cancer·2025
Same author

Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series.

Nature communications·2025
Same author

Promoting functional independence and reducing the risk of hospital-associated deconditioning for acutely hospitalised older adults: a group concept mapping service evaluation.

Disability and rehabilitation·2025
Same author

Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy.

Scientific reports·2025

Related Experiment Video

Updated: May 4, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.0K

Pediatric myelodysplastic syndromes: they do exist!

Taly Glaubach1, Lisa J Robinson, Seth J Corey

  • 1*Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago †Robert H. Lurie Comprehensive Cancer Center, Chicago, IL ‡Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA §Department of Cell & Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Journal of Pediatric Hematology/Oncology
|December 19, 2013
PubMed
Summary

Pediatric myelodysplastic syndromes (MDS) are rare but distinct from adult forms, often presenting with hypocellular marrow and monosomy 7. Diagnosis and management require specialized hematopathology expertise.

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

10.8K

Related Experiment Videos

Last Updated: May 4, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.0K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

10.8K

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Genetics

Background:

  • Myelodysplastic syndrome (MDS) is a common adult hematologic malignancy.
  • Pediatric MDS is uncommon but can be the initial sign of inherited bone marrow failure syndromes.
  • Pediatric MDS differs from adult MDS, often showing hypocellular bone marrow and monosomy 7.

Purpose of the Study:

  • To review the epidemiology, genetics, and clinical spectrum of pediatric MDS.
  • To highlight diagnostic and therapeutic challenges in pediatric MDS.
  • To compare and contrast pediatric and adult MDS.

Main Methods:

  • Literature review
  • Comparative analysis of pediatric and adult MDS data
  • Synthesis of current knowledge on pediatric MDS

Main Results:

  • Pediatric MDS is characterized by hypocellular bone marrow and monosomy 7, unlike adult MDS.
  • Refractory cytopenia is more common in pediatric MDS than refractory anemia.
  • Pediatric MDS diagnosis and management are complex, requiring expert hematopathologist input.

Conclusions:

  • Pediatric MDS is a distinct entity requiring specialized diagnostic and therapeutic approaches.
  • Understanding the unique features of pediatric MDS is crucial for improved patient outcomes.
  • Further research is needed to elucidate the specific genetic and clinical nuances of pediatric MDS.